Effect of Pasta on Blood Glucose Response in Normal Subjects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Frank Q. Nuttall, MD, PhD, Minneapolis Veterans Affairs Medical Center
ClinicalTrials.gov Identifier:
NCT01469312
First received: November 3, 2011
Last updated: November 9, 2011
Last verified: November 2011

November 3, 2011
November 9, 2011
April 2010
October 2011   (final data collection date for primary outcome measure)
Change in Blood Glucose [ Time Frame: 0, 30, 60, 90, 120, and 180 minutes after ingestion ] [ Designated as safety issue: No ]
Blood glucose will be determined by finger stick.
Same as current
Complete list of historical versions of study NCT01469312 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Pasta on Blood Glucose Response in Normal Subjects
Effect of Pasta on Blood Glucose Response in Normal Subjects

The objective of this study is to determine whether ingestion of modified pasta products (Dreamfields, Miracle Noodles) result in an improvement in blood glucose concentration when compared with a traditional pasta.

On one occasion the pasta will be a traditionally available pasta; on another occasion, approximately 1 week later a modified pasta, advertised to contain ~ 5 grams of digestible carbohydrate, or to be low in digestible starch, will be studied.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
  • Blood Glucose Concentration
  • Type 2 Diabetes
  • Metabolic Syndrome
Other: modified pasta
50 grams carbohydrate as a single breakfast meal
Other Name: Dreamfields Pasta, Miracle Noodles
  • Placebo Comparator: Control
    The control arm consists of the traditional pasta.
    Intervention: Other: modified pasta
  • Active Comparator: Modified pasta
    Dreamfields, Miracle Noodles
    Intervention: Other: modified pasta
Nuttall FQ, Schweim K, Hoover H, Gannon MC. Effect of the LoBAG30 diet on blood glucose control in people with type 2 diabetes. Br J Nutr. 2008 Mar;99(3):511-9. Epub 2007 Sep 10.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
October 2011
October 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Normal blood glucose concentration
Both
18 Years to 90 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01469312
4231
No
Frank Q. Nuttall, MD, PhD, Minneapolis Veterans Affairs Medical Center
Minneapolis Veterans Affairs Medical Center
Not Provided
Principal Investigator: Frank Q Nuttall, M.D., Ph.D. Minneapolis VA Health Care System
Principal Investigator: Mary C Gannon, Ph.D. Minneapolis VA Health Care System
Minneapolis Veterans Affairs Medical Center
November 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP